Timpani Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Timpani Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-47,486	Closed	-$3.26M	–	106
2016 Q2	$3.26M	Sell	47,486 -13,087	-22%	-$903K	1.38%	26
2016 Q1	$4.32M	Buy	60,573 +3,108	+5%	+$195K	1.83%	17
2015 Q4	$3.57M	Buy	57,465 +602	+1%	+$36.7K	1.45%	24
2015 Q3	$3.22M	Sell	56,863 -19,504	-26%	-$1.03M	1.3%	24
2015 Q2	$4.1M	Sell	76,367 -23,747	-24%	-$1.16M	1.19%	36
2015 Q1	$4.75M	Buy	100,114 +19,068	+24%	+$844K	1.42%	24
2014 Q4	$3.51M	Buy	81,046 +37,441	+86%	+$1.53M	1.38%	30
2014 Q3	$1.5M	Buy	43,605 +2,108	+5%	+$74.4K	0.69%	59
2014 Q2	$1.52M	Buy	+41,497	New	+$1.41M	0.68%	58

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Timpani Capital Management's CMD Position: Q3 2016 in Review

Timpani Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2016, closing a stake of 47,486 shares — an estimated $3.26M sold.

Timpani Capital Management first reported a position in CMD in Q2 2014 and held it in 9 quarters. The position peaked at $4.75M in Q1 2015. 227 funds tracked by Wall St. Rank hold CMD as of Q3 2016.

Timpani Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2016 after selling out during the quarter.
Timpani Capital Management sold 47,486 Cantel Medical Corporation shares in Q3 2016, an estimated $3.26M.
Timpani Capital Management first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 9 quarters.
Timpani Capital Management's Cantel Medical Corporation position peaked at $4.75M in Q1 2015.
227 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2016.

Based on Timpani Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.